adenosine monophosphate has been researched along with Cardiac Remodeling, Ventricular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bryant, JA; Bulluck, H; Chai, P; Chan, MHH; Chan, MY; Chawla, A; Chua, TS; Chung, YC; Fei, G; Hausenloy, DJ; Ho, AFW; Ho, HH; Hock, MOE; Hoe, AJ; Imran, SS; Lee, CH; Liew, BW; Lim, SH; Paradies, V; Roe, MT; Tan, JW; Teo, L; Watson, T; Wong, AS; Wong, E; Wong, PE; Yun, PLZ | 1 |
Chen, X; Cheng, J; Hong, J; Li, J; Lin, J; Zhao, J; Zheng, C | 1 |
Chen, H; Chen, JX; Gan, L; He, JH; Jiang, W; Li, RL; Li, YX; Tong, MM; Wang, M; Wang, XL; Wang, XX; Wu, SS; Wu, Y; Zhang, HY; Zhu, Y | 1 |
1 trial(s) available for adenosine monophosphate and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Platelet inhibition to target reperfusion injury trial: Rationale and study design.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Coronary Circulation; Double-Blind Method; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; ST Elevation Myocardial Infarction; Treatment Outcome; Ventricular Remodeling; Young Adult | 2019 |
2 other study(ies) available for adenosine monophosphate and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
[Role of cyclic adenosine monophosphate response element binding protein in ventricular pacing induced cardiac electrical remodeling in a canine model].
Topics: Adenosine Monophosphate; Animals; Atrial Remodeling; Blotting, Western; Cardiac Pacing, Artificial; Dogs; Echocardiography; Electrocardiography; Heart Ventricles; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Response Elements; Ventricular Remodeling | 2015 |
SIRT6 protects cardiomyocytes against ischemia/reperfusion injury by augmenting FoxO3α-dependent antioxidant defense mechanisms.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Antioxidants; Apoptosis; Catalase; Cells, Cultured; Down-Regulation; Forkhead Box Protein O3; Forkhead Transcription Factors; In Vitro Techniques; Male; Mice; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Sirtuins; Superoxide Dismutase; Ventricular Remodeling | 2016 |